Yasmeen Rahimi

Aug 25, 2026

Yasmeen Rahimi rated AGMB as Overweight on Aug 25, 2026, setting a price target of 60. Shares have remained stable near 13.94, leaving the 60 target still in play.

Jul 13, 2026

On Jul 13, 2026, EQ was given a Overweight rating by Yasmeen Rahimi, with a target price of 20. Despite the Buy call, shares fell from 2.42 to 2.42, challenging the optimistic stance.

Jun 12, 2026

TENX received a Overweight rating from Yasmeen Rahimi on Jun 12, 2026, aiming for 50. The rating hasn’t played out as hoped, with the stock trading 83.01% below expectations.

May 20, 2026

On May 20, 2026, Yasmeen Rahimi published a Overweight outlook on DRUG, with a target of 220. Market action contradicted the Buy thesis, as shares slipped to 65.

May 11, 2026

Yasmeen Rahimi on May 11, 2026 assigned AVTX a Overweight rating, with a price target of 60. The call has struggled to gain traction, with shares losing 15.16%.

May 08, 2026

On May 08, 2026, Yasmeen Rahimi reaffirmed NKTR with a Overweight rating, targeting 192. Shares slid 13.73% despite the recommendation, highlighting downside risks.

May 04, 2026

ANAB was rated Overweight by Yasmeen Rahimi on May 04, 2026, with a price objective of 93. This case shows how bullish projections can fail, with the stock now below 55.16.

Apr 16, 2026

On Apr 16, 2026, Yasmeen Rahimi initiated coverage on ROIV with a Overweight rating and target of 40. The stock’s climb of 40.25% since the call highlights the foresight in the rating.

Mar 12, 2026

On Mar 12, 2026, PLRX was evaluated by Yasmeen Rahimi, who gave a Overweight rating and target of 4. Investors saw limited payoff as shares fell short of the 4 target.

Mar 04, 2026

Yasmeen Rahimi rated ARCT as Overweight on Mar 04, 2026, setting a price target of 72. Shares have remained stable near 13.98, leaving the 72 target still in play.

Feb 13, 2026

On Feb 13, 2026, CLYM was given a Overweight rating by Yasmeen Rahimi, with a target price of 23. The stock rallied 163.67% after the rating, narrowing the gap to the target of 23 and validating the bullish stance.

Jan 29, 2026

KRRO received a Overweight rating from Yasmeen Rahimi on Jan 29, 2026, aiming for 30. Price action was muted, as shares hovered around 13.06 despite the bullish outlook.

Jan 28, 2026

On Jan 28, 2026, Yasmeen Rahimi published a Overweight outlook on PRAX, with a target of 1200. Shares gained 9.24%, underscoring the accuracy of the bullish outlook toward 1200.

Jan 28, 2026

Yasmeen Rahimi on Jan 28, 2026 assigned STTK a Overweight rating, with a price target of 15. The Buy call aligned well with market performance, producing a gain of 47.48%.

Jan 27, 2026

On Jan 27, 2026, Yasmeen Rahimi reaffirmed BIOA with a Overweight rating, targeting 73. Shares slid 55.87% despite the recommendation, highlighting downside risks.

Dec 29, 2025

PALI was rated Overweight by Yasmeen Rahimi on Dec 29, 2025, with a price objective of 25. This case shows how bullish projections can fail, with the stock now below 2.01.

Dec 19, 2025

On Dec 19, 2025, Yasmeen Rahimi initiated coverage on MDGL with a Overweight rating and target of 900. The Buy call has yet to be validated as shares remain 366.88 away from the target.

Dec 18, 2025

Yasmeen Rahimi issued a Overweight recommendation for ORKA on Dec 18, 2025, price target set at 75. The target of 75 remains in play, though confirmation will depend on future moves.

Oct 28, 2025

On Oct 28, 2025, PRTA was evaluated by Yasmeen Rahimi, who gave a Overweight rating and target of 36. Investors saw limited payoff as shares fell short of the 36 target.

Oct 06, 2025

Yasmeen Rahimi rated LBRX as Overweight on Oct 06, 2025, setting a price target of 78. The call has proven timely, with shares rising 205.48% toward the price target of 78.

Aug 27, 2025

IVA received a Overweight rating from Yasmeen Rahimi on Aug 27, 2025, aiming for 26. The rating hasn’t played out as hoped, with the stock trading 20.84% below expectations.

Jun 23, 2025

On Jun 23, 2025, Yasmeen Rahimi published a Overweight outlook on VRNA, with a target of 160. Shares gained 10.16%, underscoring the accuracy of the bullish outlook toward 160.

Apr 02, 2025

Yasmeen Rahimi on Apr 02, 2025 assigned EWTX a Overweight rating, with a price target of 51. The Buy call aligned well with market performance, producing a gain of 176.42%.

Mar 07, 2025

On Mar 07, 2025, Yasmeen Rahimi reaffirmed LXRX with a Overweight rating, targeting 6. The recommendation was supported by strong follow-through as the stock rose from 2.02 to 2.02.

Sep 23, 2024

NAMS was rated Overweight by Yasmeen Rahimi on Sep 23, 2024, with a price objective of 37. A bullish response from the market helped close the gap of 15.14 to the target.

Sep 19, 2024

On Sep 19, 2024, Yasmeen Rahimi initiated coverage on ZURA with a Overweight rating and target of 26. The stock’s climb of 25.12% since the call highlights the foresight in the rating.

Aug 14, 2024

Yasmeen Rahimi issued a Overweight recommendation for SLRN on Aug 14, 2024, price target set at 20. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Jul 16, 2024

On Jul 16, 2024, IMUX was evaluated by Yasmeen Rahimi, who gave a Overweight rating and target of 28. Investors saw limited payoff as shares fell short of the 28 target.

Jul 02, 2024

Yasmeen Rahimi rated CRNX as Overweight on Jul 02, 2024, setting a price target of 97. The call has proven timely, with shares rising 86.54% toward the price target of 97.

Jun 21, 2024

On Jun 21, 2024, ALT was given a Overweight rating by Yasmeen Rahimi, with a target price of 25. Despite the Buy call, shares fell from 3.29 to 3.29, challenging the optimistic stance.

Jun 13, 2024

BNTC received a Overweight rating from Yasmeen Rahimi on Jun 13, 2024, aiming for 30. Momentum has favored the Buy call, with shares climbing from 12.22 to 12.22, rewarding those who trusted the recommendation.

May 07, 2024

On May 07, 2024, Yasmeen Rahimi published a Overweight outlook on DSGN, with a target of 12. Shares gained 215.57%, underscoring the accuracy of the bullish outlook toward 12.